(Q35587263)

9 August 2017

1 reference

title

Post Magpie: how should we be managing severe preeclampsia? (English)

1 reference

9 August 2017

0 references

0 references

2

Michael A Belfort

1 reference

9 August 2017

Antonio E. Frias

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14624215

3 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14624215

3 April 2024

publication date

1 December 2003

1 reference

full work available at URL

9 August 2017

https://journals.lww.com/00001703-200312000-00006

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Current Opinion in Obstetrics and Gynecology

3 April 2024

published in

1 reference

9 August 2017

volume

15

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

489-495

1 reference

Contemporary concepts of the pathogenesis and management of preeclampsia

9 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group

3 April 2024

3

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Molecular epidemiology of preeclampsia

3 April 2024

4

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Maternal mortality during hospital admission for delivery: a retrospective analysis using a state-maintained database

3 April 2024

6

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Maternal mortality associated with eclampsia and severe preeclampsia of pregnancy

3 April 2024

7

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia

3 April 2024

9

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia

3 April 2024

10

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia.

3 April 2024

11

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk

3 April 2024

13

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Mild gestational hypertension remote from term: progression and outcome.

3 April 2024

15

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Maternal mortality during hospital admission for delivery: a retrospective analysis using a state-maintained database

3 April 2024

17

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Prenatal screening, epidemiology, diagnosis, and management of preeclampsia

3 April 2024

18

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Expectant management of severe preeclampsia remote from term

3 April 2024

19

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Expectant management of early onset, severe pre-eclampsia: perinatal outcome

3 April 2024

21

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Expectant management of early onset, severe pre-eclampsia: maternal outcome

3 April 2024

22

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial

3 April 2024

24

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Conservative management of early-onset pre-eclampsia and fetomaternal outcome in Nigerians

3 April 2024

25

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

3 April 2024

Medscape women's health

26

7

1

Begum

2002

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial

3 April 2024

28

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Magnesium for preventing and treating eclampsia: time for international action.

3 April 2024

29

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Alcohol handrubs v soap. Alcohol handrub removes methicillin resistant Staphylococcus aureus

3 April 2024

30

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Preventing and treating eclamptic seizures

3 April 2024

32

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study.

3 April 2024

34

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.

3 April 2024

35

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

Cerebral perfusion pressure, and not cerebral blood flow, may be the critical determinant of intracranial injury in preeclampsia: A new hypothesis

3 April 2024

36

1 reference

https://api.crossref.org/works/10.1097/00001703-200312000-00006

3 April 2024

Identifiers

1 reference

9 August 2017

1 reference